Member Sign In
Member Sign Out
Cancer & Disease Research
Create a FREE account so you can:
Get the latest life sciences research and
industry news, delivered straight to your
inbox, for FREE.
Enter your Email Address to become a member:
Already have an account?
Sign in using your social networking account:
Sign in using your social networking
Forgot your password?
Pfizer to acquire Seagen for $43 billion
Pfizer will acquire Seagen, a firm specializing in the discovery and development of treatments for cancer, the firms announced on Monday.
Exclusion of racial groups from cancer genomics research has negative impacts
The lack of genomic research for people with African ancestry is hampering efforts to reduce health disparities for people with cancer, according to recent research.
Correlation of enzyme to survival reveals potential target for metastatic solid tumors
The enzyme lysyl hydroxylase 1 (LH1) promotes the migration and metastasis of solid tumor cells and is associated with shorter survival, according to a recent study published in
Protein expression biomarker may identify likely responders to potential breast cancer drug
Targeting women who express certain proteins could increase the response rate to a breast cancer drug that achieved mixed results in previous clinical trials, according to a paper published in
EMBO Molecular Medicine
Modifying messenger RNA provides new Alzheimer’s disease target
Researchers in China have found that reducing the methylation of a key messenger RNA can promote the migration of macrophages into the brain and ameliorate symptoms of Alzheimer’s disease in mice.
Study supports genetic testing for people with cerebral palsy
A meta-analysis of recent research on the genetics of cerebral palsy provides evidence that genetic testing should be offered as the standard of care for people with the disorder.
Illumina, Myriad Genetics provide U.S. access to HRD research test
Illumina and Myriad Genetics have expanded a strategic partnership aimed at broadening access to oncology homologous recombination deficiency (HRD) testing for oncology.
Collaborative research helps long-COVID patients recover
NIH Directors Blog
posted on Wednesday, Dr. Gary Gibbons of the National Heart, Lung, and Blood Institute writes about a National Institutes of Health (NIH) initiative, Researching COVID to Enhance Recovery (RECOVER).
Stem cell-loaded plug improves outcomes in hard-to-treat Crohn’s disease patients
Most Crohn’s disease patients experienced complete clinical healing of perianal fistulas after treatment with a stem cell-loaded plug, according to data published in the journal
Diseases of the Colon & Rectum
Active surveillance on the rise for low-risk prostate cancer
A large study indicates that active surveillance rates for managing low-risk prostate cancer are rising nationally, but are still suboptimal.
More Conferences »»
Sophia Genetics partnering with Agilent Technologies to offer cancer analysis solution
Theratechnologies data suggests tesamorelin may improve metabolic profiles in people with HIV
Quanterix expands laboratory-developed-test menu with launch of neurofilament light chain test
Grail launches methylation-based liquid biopsy solution for cancer research in a post-diagnosis setting
Blood test helps diagnose inaccessible brain tumors
More articles »
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Tweets by @ScienceBoard